| 1 |
Galindo RJ, Fayfman M, Umpierrez GE. Perioperative management of hyperglycemia and diabetes in cardiac surgery patients [J]. Endocrinol Metab Clin North Am, 2018, 47(1): 203-222.
|
| 2 |
Niu M, Chen P. Crosstalk between gut microbiota and sepsis [J]. Burns Trauma, 2021, 9: tkab036.
|
| 3 |
Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia [J]. Lancet, 2009, 373(9677): 1798-1807.
|
| 4 |
Bagshaw SM, Egi M, George C, et al. Early blood glucose control and mortality in critically ill patients in australia [J]. Crit Care Med, 2009, 37(2): 463-470.
|
| 5 |
Bagshaw SM, Bellomo R, Jacka MJ, et al. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness [J]. Crit Care, 2009, 13(3): R91.
|
| 6 |
Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and icu mortality: a retrospective cohort study [J]. Crit Care, 2013, 17(2): R52.
|
| 7 |
Berghe GVD, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients [J]. N Engl J Med, 2001, 345(19): 1359-1367.
|
| 8 |
Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU [J]. N Engl J Med, 2006, 354(5): 449-461.
|
| 9 |
Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study [J]. Intensive Care Med, 2009, 35(10): 1738-1748.
|
| 10 |
Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J]. N Engl J Med, 2008, 358(2): 125-139.
|
| 11 |
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients [J]. N Engl J Med, 2009, 360(13): 1283-1297.
|
| 12 |
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of critical care medicine (sccm) and american society for parenteral and enteral nutrition (a.S.P.E.N.) [J]. JPEN J Parenter Enteral Nutr, 2016, 40(2): 159-211.
|
| 13 |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
|
| 14 |
中华医学会神经外科学分会, 中国神经外科重症管理协作组. 中国神经外科重症管理专家共识 (2020版) [J]. 中华医学杂志, 2020, 100(19): 1443-1458.
|
| 15 |
Truog RD. Translating research on communication in the intensive care unit into effective educational strategies [J]. Crit Care Med, 2010, 38(3): 976-977.
|
| 16 |
Bohé J, Abidi H, Brunot V, et al; CONTROLe INdividualisé de la Glycémie (CONTROLING) Study Group. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial [J]. Intensive Care Med, 2021, 47(11): 1271-1283.
|
| 17 |
Wu Z, Liu J, Zhang D, et al. Expert consensus on the glycemic management of critically ill patients [J]. Intensive Med, 2022, 2(3): 131-145.
|
| 18 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南 (2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 95.
|
| 19 |
Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in norfolk cohort of european prospective investigation of cancer and nutrition (epic-norfolk) [J]. BMJ, 2001, 322(7277): 15.
|
| 20 |
Lee YS, Min KH, Lee SY, et al. The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis [J]. PLoS One, 2019, 14(5): e0216397.
|
| 21 |
Alhatemi G, Aldiwani H, Alhatemi R, et al. Glycemic control in the critically ill: less is more [J]. Cleve Clin J Med, 2022, 89(4): 191-9.
|
| 22 |
Krinsley JS. Glycemic variability: A strong independent predictor of mortality in critically ill patients [J]. Crit Care Med, 2008, 36(11): 3008-3013.
|
| 23 |
Hirsch IB. Glycemic variability: It's not just about a1c anymore! [J]. Diabetes Technol Ther, 2005, 7(5): 780-783.
|
| 24 |
Subramaniam B, Lerner A, Novack V, et al. Increased glycemic variability in patients with elevated preoperative HbA1c predicts adverse outcomes following coronary artery bypass grafting surgery [J]. Anesth Analg, 2014, 118(2): 277-287.
|
| 25 |
Lanspa MJ, Dickerson J, Morris AH, et al. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin [J]. Crit Care, 2014, 18(2): R86.
|
| 26 |
Atamna A, Ayada G, Akirov A, et al. High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection [J]. QJM, 2019, 112(2): 101-106.
|
| 27 |
Chase JG, Pretty CG, Pfeifer L, et al. Organ failure and tight glycemic control in the SPRINT study [J]. Crit Care, 2010, 14(4): R154.
|
| 28 |
Signal M, Compte AL, Shaw GM, et al. Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes? [J]. J Diabetes Sci Technol, 2012, 6(5): 1030.
|
| 29 |
Lanspa MJ, Krinsley JS, Hersh AM, et al. Percentage of time in range 70 to 139 mg/dl is associated with reduced mortality among critically ill patients receiving iv insulin infusion [J]. Chest, 2019, 156(5): 878-886.
|
| 30 |
中华医学会糖尿病学分会. 中国血糖监测临床应用指南 (2021年版) [J]. 中华糖尿病杂志, 2021, 13(10): 13.
|
| 31 |
Raurell-Torreda M, Del Llano-Serrano C, Almirall-Solsona D, et al. Arterial catheter setup for glucose control in critically ill patients: A randomized controlled trial [J]. Am J Crit Care, 2014, 23(2): 150-159.
|
| 32 |
Critchell CD, Savarese V, Callahan A, et al. Accuracy of bedside capillary blood glucose measurements in critically ill patients [J]. Intensive Care Med, 2007, 33(12): 2079-2084.
|
| 33 |
Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients [J]. Crit Care Med, 2012, 40(12): 3251-3276.
|
| 34 |
Juneja R, Roudebush CP, Nasraway SA, et al. Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time [J]. Crit Care, 2009, 13(5): R163.
|
| 35 |
American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes-2021 [J]. Diabetes Care, 2021, 44(Suppl 1): S73-S84.
|
| 36 |
Sun MT, Li IC, Lin WS, et al. Pros and cons of continuous glucose monitoring in the intensive care unit [J]. World J Clin Cases, 2021, 9(29): 8666-8670.
|
| 37 |
Yao Y, Zhao YH, Zheng WH, et al. Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: A meta-analysis [J]. Am J Transl Res, 2022, 14(7): 4757.
|
| 38 |
Preiser JC, Lheureux O, Thooft A, et al. Near-continuous glucose monitoring makes glycemic control safer in icu patients [J]. Crit Care Med, 2018, 46(8): 1224-1229.
|
| 39 |
Chow KW, Kelly DJ, Rieff MC, et al. Outcomes and healthcare provider perceptions of real-time continuous glucose monitoring (rtcgm) in patients with diabetes and COVID-19 admitted to the ICU [J]. J Diabetes Sci Technol, 2021, 15(3): 607-614.
|
| 40 |
Shelden D, Ateya M, Jensen A, et al. Improving hospital glucometrics, workflow, and outcomes with a computerized intravenous insulin dose calculator built into the electronic health record [J]. J Diabetes Sci Technol, 2021, 15(2): 271-278.
|
| 41 |
Chen C, Zhao XL, Li ZH, et al. Current and emerging technology for continuous glucose monitoring [J]. Sensors (Basel), 2017, 17(1): 182.
|
| 42 |
贾伟平. 中国动态血糖监测临床应用指南 (2012年版) [J]. 慢性病学杂志, 2013, (5): 10.
|
| 43 |
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit [J]. Clin Nutr, 2019, 38(1): 48-79.
|
| 44 |
Pletschette Z, Preiser JC. Continuous versus intermittent feeding of the critically ill: Have we made progress? [J]. Curr Opin Crit Care, 2020, 26(4): 341-345.
|
| 45 |
Bear DE, Hart N, Puthucheary Z. Continuous or intermittent feeding: Pros and cons [J]. Curr Opin Crit Care, 2018, 24(4): 256-261.
|
| 46 |
Ren CJ, Yao B, Tuo M, et al. Comparison of sequential feeding and continuous feeding on the blood glucose of critically ill patients: A non-inferiority randomized controlled trial [J]. Chin Med J (Engl), 2021, 134(14): 1695-1700.
|
| 47 |
Kouw IWK, Heilbronn LK, van Zanten ARH. Intermittent feeding and circadian rhythm in critical illness [J]. Curr Opin Crit Care, 2022, 28(4): 381-388.
|
| 48 |
Heyland DK, Cahill NE, Dhaliwal R, et al. Enhanced protein-energy provision via the enteral route in critically ill patients: a single center feasibility trial of the Pep Up protocol [J]. Crit Care, 2010, 14(2): R78.
|
| 49 |
Roberts S, Brody R, Rawal S, et al. Volume-based vs rate-based enteral nutrition in the intensive care unit: impact on nutrition delivery and glycemic control [J]. JPEN J Parenter Enteral Nutr, 2019, 43(3): 365-375.
|
| 50 |
Bharal M, Morgan S, Husain T, et al. Volume based feeding versus rate based feeding in the critically ill: a UK study [J]. J Intensive Care Soc, 2019, 20(4): 299-308.
|
| 51 |
Prest PJ, Justice J, Bell N, et al. A volume-based feeding protocol improves nutrient delivery and glycemic control in a surgical trauma intensive care unit [J]. JPEN J Parenter Enteral Nutr, 2020, 44(5): 880-888.
|